Pharmaron Beijing Co., Ltd. (300759.SZ)
CNY 27.78
(-0.71%)
CNY 27.78
(-0.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 11.53 Billion | 10.26 Billion | 7.44 Billion | 5.13 Billion | 3.75 Billion | 2.9 Billion |
| Cost of Revenue | 7.65 Billion | 6.49 Billion | 4.76 Billion | 3.21 Billion | 2.42 Billion | 1.96 Billion |
| Gross Profit | 3.88 Billion | 3.76 Billion | 2.67 Billion | 1.92 Billion | 1.33 Billion | 944.66 Million |
| Operating Expenses | 2.27 Billion | 2.01 Billion | 1.15 Billion | 838.94 Million | 630.23 Million | 503.53 Million |
| Selling, General and Administrative Expenses | 1.68 Billion | 969.48 Million | 410.43 Million | 388.28 Million | 295.4 Million | 182.88 Million |
| Research and Development Expenses | 448.27 Million | 282.32 Million | 151.77 Million | 105.34 Million | 62.87 Million | 31.61 Million |
| Other Expenses | -75.47 Million | 766 Million | 591.84 Million | 345.31 Million | 271.95 Million | 20.46 Million |
| Cost and Expenses | 9.69 Billion | 8.51 Billion | 5.91 Billion | 4.04 Billion | 3.05 Billion | 2.46 Billion |
| Operating Income | 1.84 Billion | 1.68 Billion | 1.91 Billion | 1.32 Billion | 631.48 Million | 380.04 Million |
| Interest Expense | 182.19 Million | 167.31 Million | 83.07 Million | 23.85 Million | 82.47 Million | 71.62 Million |
| Income Tax Expense | 256.1 Million | 314.25 Million | 290.91 Million | 172.37 Million | 101.87 Million | 61.48 Million |
| Earnings before Tax | 1.83 Billion | 1.66 Billion | 1.91 Billion | 1.31 Billion | 632.55 Million | 400.5 Million |
| Net Income | 1.6 Billion | 1.37 Billion | 1.66 Billion | 1.17 Billion | 547.19 Million | 339.22 Million |
| Earnings Per Share Basic | 0.90 | 0.78 | 0.93 | 0.66 | 0.37 | 0.38 |
| Earnings Per Share Diluted | 0.90 | 0.77 | 0.91 | 0.66 | 0.37 | 0.38 |
| Weighted Average Shares Outstanding | 1.77 Billion | 1.77 Billion | 1.78 Billion | 1.77 Billion | 1.48 Billion | 886.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.77 Billion | 1.77 Billion | 1.8 Billion | 1.78 Billion | 1.48 Billion | 886.07 Million |
| Gross Margin | 0.34 | 0.37 | 0.36 | 0.37 | 0.36 | 0.32 |
| EBIT Margin | 0.26 | 0.25 | 0.35 | 0.32 | 0.27 | 0.24 |
| Profit Margin | 0.14 | 0.13 | 0.22 | 0.23 | 0.15 | 0.12 |
| EBITDA | 3.03 Billion | 2.63 Billion | 2.49 Billion | 1.8 Billion | 1.03 Billion | 700.55 Million |
| Earnings Before Tax Margin | 0.16 | 0.16 | 0.26 | 0.26 | 0.17 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 3.21 Billion | 2.9 Billion | 2.64 Billion | 11.45 Billion | 2.95 Billion | 2.92 Billion |
| Cost of Revenue | 2.09 Billion | 1.99 Billion | 1.79 Billion | 7.65 Billion | 1.99 Billion | 1.89 Billion |
| Gross Profit | 1.11 Billion | 904.8 Million | 842.49 Million | 3.8 Billion | 961.87 Million | 1.02 Billion |
| Operating Expenses | 602.94 Million | 538.1 Million | 554.15 Million | 2.11 Billion | 562.92 Million | 571.88 Million |
| Selling, General and Administrative Expenses | 1 Billion | 433.01 Million | 460.29 Million | - | 412.45 Million | 886.31 Million |
| Research and Development Expenses | 124.45 Million | 105.34 Million | 93.6 Million | - | 144 Million | 114.58 Million |
| Other Expenses | -528.69 Million | 252.51 Thousand | -254.35 Thousand | -8.56 Million | -6.47 Million | -46.6 Million |
| Cost and Expenses | 2.7 Billion | 2.53 Billion | 2.35 Billion | 9.76 Billion | 2.55 Billion | 2.46 Billion |
| Operating Income | 397.99 Million | 366.69 Million | 288.34 Million | 1.68 Billion | 398.94 Million | 414.6 Million |
| Interest Expense | 55.16 Million | 67.68 Million | 70.56 Million | 182.19 Million | 48.1 Million | 45.06 Million |
| Income Tax Expense | 108.76 Million | 91.2 Million | 52.69 Million | 256.1 Million | 69.68 Million | 61.96 Million |
| Earnings before Tax | 395.02 Million | 976.05 Million | 281.1 Million | 1.83 Billion | 530.3 Million | 412.41 Million |
| Net Income | 308.39 Million | 882.84 Million | 230.55 Million | 1.6 Billion | 462.05 Million | 352.94 Million |
| Earnings Per Share Basic | 0.17 | 0.50 | 0.13 | - | 0.26 | 0.30 |
| Earnings Per Share Diluted | 0.17 | 0.50 | 0.13 | - | 0.26 | 0.20 |
| Weighted Average Shares Outstanding | 1.78 Billion | 1.77 Billion | 1.78 Billion | 1.77 Billion | 1.77 Billion | 1.19 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.78 Billion | 1.77 Billion | 1.78 Billion | 1.77 Billion | 1.77 Billion | 1.76 Billion |
| Gross Margin | 0.35 | 0.31 | 0.32 | 0.33 | 0.33 | 0.35 |
| EBIT Margin | 0.14 | 0.22 | 0.14 | - | 0.22 | 0.14 |
| Profit Margin | 0.10 | 0.30 | 0.09 | 0.14 | 0.16 | 0.12 |
| EBITDA | 450.19 Million | 644.09 Million | 366.77 Million | - | 662.39 Million | 421.08 Million |
| Earnings Before Tax Margin | 0.12 | 0.13 | 0.11 | 0.15 | 0.14 | 0.14 |
301011
9039
1259
CENTURYTEX
UNOMINDA
PRKA